Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZTS Zoetis Inc.

马丁-路德-金纪念日休市 01-16 16:00:00 EST

124.65

-0.63

-0.50%

盘后124.60

-0.05-0.04%

19:31 EST

最高125.90	最低123.47	成交量704.85万
今开125.34	昨收125.28	日振幅1.94%
总市值549.32亿	流通市值549.32亿	总股本4.41亿
成交额8.79亿	换手率1.60%	流通股本4.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":124.65,"timestamp":1768597200000,"preClose":125.28,"halted":0,"volume":7048452,"hourTrading":{"tag":"盘后","latestPrice":124.5958,"preClose":124.65,"latestTime":"19:31 EST","volume":1441472,"amount":179679155.03684,"timestamp":1768609917618,"change":-0.0542,"changeRate":-0.000435,"amplitude":0.001685},"delay":0,"changeRate":-0.0050287356321838715,"floatShares":440693214,"shares":440693214,"eps":5.936625,"marketStatus":"马丁-路德-金纪念日休市","change":-0.63,"latestTime":"01-16 16:00:00 EST","open":125.34,"high":125.9,"low":123.47,"amount":879102140.4717,"amplitude":0.019397,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.936625,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":125.28,"dividendRate":0.015499,"preHourTrading":{"tag":"盘前","latestPrice":125,"preClose":125.28,"latestTime":"09:22 EST","volume":275,"amount":34464.3035,"timestamp":1768573321833,"change":-0.28,"changeRate":-0.002235,"amplitude":0.009935},"postHourTrading":{"tag":"盘后","latestPrice":124.5958,"preClose":124.65,"latestTime":"19:31 EST","volume":1441472,"amount":179679155.03684,"timestamp":1768609917618,"change":-0.0542,"changeRate":-0.000435,"amplitude":0.001685},"volumeRatio":1.6719599165681591,"impliedVol":0.3707,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/ZTS","defaultTab":"news","newsList":[{"id":"1194652354","title":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=1194652354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194652354?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:20","pubTimestamp":1765866012,"startTime":"0","endTime":"0","summary":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9505.USD","LU0058720904.USD","LU1721429402.USD","ZTS","BK4534","LU0158827781.USD","LU0158827948.USD","LU1941712264.USD","LU0471298777.SGD","LU0107464264.USD","LU2023251221.USD","LU0345774631.USD","LU1941712348.USD","BK4585","LU0289739699.SGD","LU0385154629.USD","LU2028103732.USD","LU2360106947.USD","BK4588","LU0345774391.USD","LU2111349929.HKD","LU0079474960.USD","BK4007","LU2271345857.HKD","LU2089283258.USD","LU0471298694.HKD","LU2308191902.HKD","LU2089284900.SGD","LU1721429741.USD"],"gpt_icon":0},{"id":"1199092124","title":"Zoetis获得加拿大卫生部批准，Portela™（Relfovetmab注射液）可缓解猫咪的骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1199092124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199092124?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941417,"startTime":"0","endTime":"0","summary":"Zoetis获得加拿大卫生部的批准，Portela™（Relfovetmab注射液）可用于缓解猫咪骨关节炎所致的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","LU0471298694.HKD","LU1721429402.USD","LU0107464264.USD","LU2271345857.HKD","LU2023251221.USD","BK4007","LU2089284900.SGD","LU0345774391.USD","LU0079474960.USD","LU0385154629.USD","BK4588","LU2028103732.USD","LU2111349929.HKD","LU0471298777.SGD","LU1941712264.USD","LU1941712348.USD","LU0289739699.SGD","BK4585","LU2308191902.HKD","LU0158827948.USD","LU1721429741.USD","LU2360106947.USD","BK4534","LU0345774631.USD","LU2089283258.USD","IE00B19Z9505.USD","LU0058720904.USD","LU0158827781.USD"],"gpt_icon":0},{"id":"1137813317","title":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1137813317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137813317?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:16","pubTimestamp":1764191777,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0385154629.USD","LU1941712264.USD","LU0345774391.USD","LU0471298694.HKD","BK4588","LU0158827781.USD","LU1941712348.USD","LU2111349929.HKD","LU0289739699.SGD","ZTS","LU2360106947.USD","LU0079474960.USD","LU0345774631.USD","LU0471298777.SGD","LU0058720904.USD","BK4534","IE00B19Z9505.USD","LU2308191902.HKD","BK4007","LU2089283258.USD","LU2089284900.SGD","LU2028103732.USD","LU2023251221.USD","BK4585","LU2271345857.HKD","LU0158827948.USD","LU0107464264.USD"],"gpt_icon":0},{"id":"1187876037","title":"异动解读 | Zoetis盘前大跌9.17%，下调年度收入预期且季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1187876037","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187876037?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:40","pubTimestamp":1762260026,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.今日盘前股价大跌9.17%，引发市场关注。该公司股价在盘前交易中跌至133美元左右，较前一交易日收盘价大幅下挫。Zoetis将全年收入预测区间调整为94.0亿美元至94.8亿美元，低于此前预测的94.5亿美元至96.0亿美元。此外，Zoetis公布的第三季度业绩也未能完全达到市场预期。值得注意的是，截至上一交易日收盘，Zoetis股价已累计下跌约11%，显示出投资者对公司近期表现的持续担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"gpt_icon":0},{"id":"1186621787","title":"Zoetis宣布Rob Polzer于2025年底退休，并任命Kevin Esch为2026年起全球动物健康领军企业的研发总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1186621787","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186621787?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:16","pubTimestamp":1762204575,"startTime":"0","endTime":"0","summary":"Zoetis宣布Rob Polzer将于2025年底退休，同时任命Kevin Esch为2026年起全球动物健康领域的研究与开发总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774391.USD","BK4585","LU2360106947.USD","LU1941712264.USD","LU2028103732.USD","LU0385154629.USD","LU2271345857.HKD","LU2111349929.HKD","BK4588","LU0158827781.USD","LU0471298694.HKD","LU0289739699.SGD","LU0471298777.SGD","LU0079474960.USD","LU0345774631.USD","IE00B19Z9505.USD","LU1941712348.USD","ZTS","LU2308191902.HKD","BK4007","LU2023251221.USD","LU2089284900.SGD","LU0107464264.USD","LU2089283258.USD","LU0058720904.USD","BK4534","LU0158827948.USD"],"gpt_icon":0},{"id":"1156037245","title":"Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1156037245","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156037245?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:23","pubTimestamp":1761744225,"startTime":"0","endTime":"0","summary":"Zoetis Inc.：*Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛* Zoetis Inc. - 预计Portela将在2026年在欧盟上市  ((路透社投资简报; email: reutersinvestor.briefs@thomsonreuters.com))  来源日期/时间 = 29-OCT-2025 12:30:00.16 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298694.HKD","BK4585","LU0345774631.USD","LU2089284900.SGD","LU2089283258.USD","BK4534","IE00B19Z9505.USD","LU2271345857.HKD","BK4588","LU2360106947.USD","LU1941712348.USD","LU0289739699.SGD","LU2111349929.HKD","LU0158827781.USD","LU1941712264.USD","LU2308191902.HKD","LU0058720904.USD","LU0107464264.USD","ZTS","BK4007","LU2023251221.USD","LU0158827948.USD","LU0079474960.USD","LU0385154629.USD","LU2028103732.USD","LU0471298777.SGD","LU0345774391.USD"],"gpt_icon":0},{"id":"1143607798","title":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权以缓解猫咪与骨关节炎相关的疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1143607798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143607798?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:30","pubTimestamp":1761741033,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权，以缓解猫咪与骨关节炎相关的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298694.HKD","LU0289739699.SGD","ZTS","LU2308191902.HKD","BK4585","LU0107464264.USD","LU0158827781.USD","LU0345774631.USD","LU0471298777.SGD","LU2028103732.USD","BK4534","BK4588","LU2360106947.USD","LU1941712264.USD","LU0079474960.USD","LU0345774391.USD","LU2089284900.SGD","LU2111349929.HKD","LU0058720904.USD","IE00B19Z9505.USD","LU0158827948.USD","BK4007","LU1941712348.USD","LU2089283258.USD","LU2271345857.HKD","LU2023251221.USD","LU0385154629.USD"],"gpt_icon":0},{"id":"1107496021","title":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1107496021","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107496021?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:01","pubTimestamp":1760526077,"startTime":"0","endTime":"0","summary":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","LU0289739699.SGD","LU0345774631.USD","BK4588","LU0079474960.USD","LU0107464264.USD","LU2271345857.HKD","BK4007","LU0345774391.USD","LU2360106947.USD","ZTS","LU1941712348.USD","LU2308191902.HKD","LU0158827781.USD","IE00B19Z9505.USD","LU0385154629.USD","BK4585","LU2111349929.HKD","LU0471298694.HKD","LU2028103732.USD","LU2089283258.USD","LU2023251221.USD","LU0471298777.SGD","LU2089284900.SGD","LU1941712264.USD","BK4534","LU0058720904.USD"],"gpt_icon":0},{"id":"1115730463","title":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，用于缓解犬类骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1115730463","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115730463?lang=zh_cn&edition=full","pubTime":"2025-10-11 04:16","pubTimestamp":1760127402,"startTime":"0","endTime":"0","summary":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，该药物用于缓解犬类骨关节炎疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","LU0345774391.USD","LU0345774631.USD","LU0079474960.USD","LU2028103732.USD","BK4007","BK4588","LU2111349929.HKD","LU2360106947.USD","LU0471298694.HKD","LU2023251221.USD","LU1941712264.USD","ZTS","LU0385154629.USD","IE00B19Z9505.USD","LU2271345857.HKD","BK4534","LU0058720904.USD","BK4585","LU0158827948.USD","LU2089283258.USD","LU2089284900.SGD","LU0107464264.USD","LU0289739699.SGD","LU1941712348.USD","LU0158827781.USD","LU0471298777.SGD"],"gpt_icon":0},{"id":"1162793149","title":"Zoetis获得Dectomax®-CA1注射剂条件性批准，用于预防和治疗牛新世界螺旋蝇蛆病","url":"https://stock-news.laohu8.com/highlight/detail?id=1162793149","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162793149?lang=zh_cn&edition=full","pubTime":"2025-10-01 04:16","pubTimestamp":1759263414,"startTime":"0","endTime":"0","summary":"Zoetis获得了其Dectomax®-CA1注射剂的条件性批准，该产品专门用于预防和治疗牛的新世界螺旋蝇蛆病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0107464264.USD","LU0385154629.USD","LU1941712264.USD","ZTS","IE00B19Z9505.USD","LU2308191902.HKD","BK4585","LU0345774391.USD","LU2089283258.USD","LU0471298777.SGD","LU2023251221.USD","LU2028103732.USD","BK4588","LU0158827948.USD","LU0079474960.USD","LU0471298694.HKD","LU2360106947.USD","LU0289739699.SGD","LU2271345857.HKD","LU0158827781.USD","LU1941712348.USD","LU2111349929.HKD","LU2089284900.SGD","LU0058720904.USD","BK4534","LU0345774631.USD","BK4007"],"gpt_icon":0},{"id":"1178037747","title":"美国卫生与公众服务部：FDA有条件批准Dectomax-CA1注射液用于预防和治疗牛类新世界螺旋蝇蛆感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1178037747","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178037747?lang=zh_cn&edition=full","pubTime":"2025-10-01 02:38","pubTimestamp":1759257500,"startTime":"0","endTime":"0","summary":"美国卫生与公众服务部宣布，美国食品药品监督管理局已有条件批准Dectomax-CA1注射液，该药物用于预防和治疗牛类新世界螺旋蝇蛆感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0471298694.HKD","BK4534","LU0158827781.USD","LU2271345857.HKD","LU0385154629.USD","LU2360106947.USD","LU2308191902.HKD","LU0289739699.SGD","LU0471298777.SGD","LU0158827948.USD","LU0345774391.USD","LU2111349929.HKD","LU2028103732.USD","LU2089283258.USD","LU0107464264.USD","LU0345774631.USD","LU0079474960.USD","LU2023251221.USD","BK4007","LU2089284900.SGD","BK4585","LU1941712264.USD","BK4588","IE00B19Z9505.USD","ZTS","LU1941712348.USD"],"gpt_icon":0},{"id":"1137499971","title":"Zoetis治疗猫骨关节炎疼痛药物Portela®获得CVMP积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1137499971","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137499971?lang=zh_cn&edition=full","pubTime":"2025-09-13 00:11","pubTimestamp":1757693477,"startTime":"0","endTime":"0","summary":"Zoetis治疗猫骨关节炎疼痛药物Portela®（Relfovetmab）获得CVMP积极意见","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU2089283258.USD","LU0107464264.USD","LU0158827948.USD","LU2111349929.HKD","ZTS","LU0058720904.USD","LU0158827781.USD","LU0345774391.USD","LU0471298777.SGD","BK4007","LU2028103732.USD","BK4534","LU2271345857.HKD","BK4585","LU0345774631.USD","LU2023251221.USD","IE00B19Z9505.USD","LU0471298694.HKD","BK4588","LU1941712264.USD","LU0385154629.USD","LU0289739699.SGD","LU2308191902.HKD","LU0079474960.USD","LU2360106947.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2558681039","title":"硕腾2025财年第二财季实现净利润7.18亿美元，同比增加15.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681039","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681039?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841662,"startTime":"0","endTime":"0","summary":"8月11日，硕腾公布财报，公告显示公司2025财年第二财季净利润为7.18亿美元，同比增加15.06%；其中营业收入为24.60亿美元，同比增加4.19%，每股基本收益为1.61美元。从资产负债表来看，硕腾总负债95.02亿美元，其中短期债务13.50亿美元，资产负债比为1.53，流动比率为1.76。机构评级：截至2025年8月11日，当前有14家机构对硕腾目标价做出预测，其中目标均价为195.36美元，其中最低目标价为153.00美元，最高目标价为230.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000223a480569d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000223a480569d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"2557378859","title":"硕腾2025半年报：总营收46.8亿美元，犬猫产品卖了近32亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557378859","media":"宠业家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557378859?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:31","pubTimestamp":1754472698,"startTime":"0","endTime":"0","summary":"结合Q1季度财报，硕腾2025上半年总营收为46.8亿美元，增长3%，净利润13.49亿美元，增长10%。上半年伴侣动物营收33.34亿美元犬猫产品卖了31.97亿美元财报显示，硕腾2025上半年伴侣动物业务营收33.34亿美元，比去年同期增长8%；牲畜业务营收12.83亿美元，增长9%。2025年上半年来自中国市场的营收为1.32亿美元。其他市场中，巴西成为硕腾最大的海外市场，2025上半年营收1.81亿美元，相比去年有所下降；其次是澳大利亚市场，上半年营收158亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806181626a4788251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806181626a4788251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"2557342554","title":"美股财报 | 硕腾发布Q2财报 前半年累计净利润同比增长10.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557342554","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557342554?lang=zh_cn&edition=full","pubTime":"2025-08-06 12:00","pubTimestamp":1754452812,"startTime":"0","endTime":"0","summary":"硕腾(ZTS)发布Q2财报，2025财年前六月累计收入46.80亿美元，去年同期累计收入为45.51亿美元，同比增长2.83%。2025财年前六月累计净利润13.49亿美元，去年同期累计净利润为12.23亿美元，同比增长10.30%。本财年累计基本每股收益为3.02美元，去年同期为2.68美元。公司所属行业为制药。【公司信息】硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806120611a477d9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806120611a477d9ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"1128331873","title":"异动解读 | Zoetis盘前大涨11.98%，上调年度预期受宠物产品需求强劲推动","url":"https://stock-news.laohu8.com/highlight/detail?id=1128331873","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128331873?lang=zh_cn&edition=full","pubTime":"2025-08-05 20:18","pubTimestamp":1754396315,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis今日盘前股价大涨11.98%，引起市场广泛关注。据报道，Zoetis将2025年的营收预期上调至94.5亿美元到96.0亿美元之间，较此前的94.3亿美元到95.8亿美元有所提升。在第二季度，Zoetis的调整后每股收益达到1.76美元，高于市场预期的1.62美元，季度收入增长4%至24.6亿美元，同样超出预期。Zoetis的强劲业绩主要得益于其伴侣动物部门的出色表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"gpt_icon":0},{"id":"2555064777","title":"特朗普拟对进口药品征收高额关税，谁最可能受影响？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555064777","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555064777?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:40","pubTimestamp":1753854000,"startTime":"0","endTime":"0","summary":"7月30日，美国总统特朗普即将对进口药品加征关税，这一政策可能最快于8月1日开始实施，并在未来一年或一年半内逐步提高税率。包括罗氏在内的多家药企高管近期对药品关税提出强烈批评，认为该政策将损害研发投入，并最终导致患者可获得的治疗选择减少。罗氏强调，药品和诊断应被排除在关税之外，以保护患者可及性和未来的医疗创新。但公司也表示，已做好准备应对潜在关税，通过库存调整等方式确保产品供应不受影响。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323364.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"特朗普拟对进口药品征收高额关税，谁最可能受影响？","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4551","PFE","LLY","BK4023","BMY","GSK","NVO","RHHBY","AMGN","BK4535","SNY","BIIB","VRTX","GILD","NVS","AZN","ZTS","MRK","BK4503"],"gpt_icon":1},{"id":"2512046953","title":"硕腾2024财年实现净利润24.86亿美元，同比增加6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512046953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512046953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721669,"startTime":"0","endTime":"0","summary":"2月17日，硕腾公布财报，公告显示公司2024财年净利润为24.86亿美元，同比增加6.06%；其中营业收入为92.56亿美元，同比增加8.33%，每股基本收益为5.47美元。从资产负债表来看，硕腾总负债94.67亿美元，其中短期债务14.01亿美元，资产负债比为1.51，流动比率为1.76。机构评级：截至2025年2月17日，当前有15家机构对硕腾目标价做出预测，其中目标均价为214.47美元，其中最低目标价为180.00美元，最高目标价为244.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"2512596924","title":"动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512596924","media":"新牧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512596924?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:43","pubTimestamp":1739702626,"startTime":"0","endTime":"0","summary":"另外，近日默沙东公布2024年财报，2024年默沙东总营收641.68亿美元，同比增长7%；2024年来自动物保健部门的营收为59亿美元，同比增长4%。2024 年第四季度净利润为5.81亿美元，摊薄每股收益为1.29美元，分别较报告期增长11%和13%。2024全年净利润为25亿美元，摊薄每股收益为5.47美元，分别较报告基础增长6%和8%。2024年，默沙东总营收641.68亿美元，同比增长7%。展望2025年，默沙东预计全球销售额将在641亿美元至656亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ZTS"],"gpt_icon":0},{"id":"2511571617","title":"硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511571617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511571617?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:50","pubTimestamp":1739566218,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时50分，硕腾股票出现波动，股价急速跳水5.02%。截至发稿，该股报156.65美元/股，成交量641.473万股，换手率1.43%，振幅4.74%。最近的财报数据显示，该股实现营业收入92.56亿美元，净利润24.86亿美元，每股收益5.47美元，毛利63.96亿美元，市盈率28.67倍。硕腾股票所在的制药行业中，整体跌幅为1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS","LU2089284900.SGD","LU2271345857.HKD","LU2023251221.USD","LU2089283258.USD","LU0471298694.HKD","LU0471298777.SGD","BK4007","LU0158827948.USD","LU0345774631.USD","LU0289739699.SGD","LU2308191902.HKD","LU2111349929.HKD","LU0058720904.USD","LU1941712264.USD","PTPI","LU0158827781.USD","LU0079474960.USD","LU0385154629.USD","BK4588","LU2028103732.USD","BK4585","LU0345774391.USD","LU1941712348.USD","IE00B19Z9505.USD","BK4534","LU2360106947.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":0.0196},{"period":"3month","weight":-0.1347},{"period":"6month","weight":-0.1612},{"period":"1year","weight":-0.264},{"period":"ytd","weight":-0.0093}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.015075},{"month":2,"riseRate":0.583333,"avgChangeRate":0.015339},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.013564},{"month":4,"riseRate":0.538462,"avgChangeRate":0.015522},{"month":5,"riseRate":0.692308,"avgChangeRate":0.026998},{"month":6,"riseRate":0.692308,"avgChangeRate":0.013528},{"month":7,"riseRate":0.846154,"avgChangeRate":0.031992},{"month":8,"riseRate":0.769231,"avgChangeRate":0.012395},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.008448},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}